Vaxcyte shareholders re-elect Class I directors, ratify Deloitte as auditor, approve say-on-pay

Vaxcyte, Inc.

Annie Drapeau re-elected with 82,886,170 votes for; Teri Loxam with 96,840,846; Carlos Paya with 96,685,408.
Ratification of Deloitte & Touche as auditor for FY 2024: 103,807,993 for, 14,745 against, 24,027 abstain.
Non-binding advisory vote on executive compensation approved: 91,072,269 for, 7,934,248 against, 23,235 abstain.
Three Class I directors to serve until 2027 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.